Trial intelligence / Profile preview

LF111 (drospirenone) for contraception

NCT02269241Phase 3Completed

Sponsor
Laboratorios Leon Farma
Start
Oct 2014
Primary completion
Oct 2017
Countries
1
01

Overview

A Phase 3 trial of drospirenone in contraception, sponsored by Laboratorios Leon Farma. Started Oct 2014; status: completed.

02

Drugs

drospirenone
03

Conditions

contraception

Beyond the preview

Go deeper on NCT02269241.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02269241.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call